Us Bancorp »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Us Bancorp

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Us Bancorp

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3k 2.0k 1.64
2025-06-30 $2.6k 2.0k 1.30
2025-03-31 $2.3k 2.0k 1.15
2024-12-31 $2.1k 2.0k 1.06
2024-09-30 $2.3k 2.0k 1.17

More positions owned by Us Bancorp

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Rus Mid Cap Etf (IWR)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)

View all positions for Us Bancorp

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
Morgan Stanley
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1